Related Experiment Video

Updated: Apr 11, 2026

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
07:56

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis

Published on: May 5, 2023

882

Is strengthening the endothelial barrier a therapeutic strategy for Ebola?

Niall C Filewod1, Warren L Lee2

  • 1Interdepartmental Division of Critical Care, University of Toronto, Toronto, Ontario, Canada.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|May 31, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Applications of TEER Detection to Assess Cell Barrier Integrity09:03

Author Spotlight: Applications of TEER Detection to Assess Cell Barrier Integrity

Published on: September 29, 2023

5.3K
Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells09:23

Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells

Published on: September 24, 2017

15.7K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
34.0K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
568